The Global Tobacco Control Research Programme
at Simon Fraser University 

Tobacco use and exposure causes more than 7 million deaths each year worldwide. If current trends continue, 1 billion deaths will be attributable to tobacco by the end of the twenty-first century. The impact of tobacco use is disproportionately borne by low- and middle-income countries, where almost 80% of the world's more than 1 billion smokers live.

The Global Tobacco Control Research Programme at Simon Fraser University (SFU) involves researchers from Canada, the UK, the US and Australia who come from a range of disciplinary backgrounds. Our research analyses a range of tobacco control issues from a commerical determinants of health perspective. 

The programme builds on previous research by team members that has produced detailed analyses of the strategies of transnational tobacco companies in a globalised economy; tobacco industry activities in low and middle-income countries; and challenges to implementation of effective tobacco control agendas.

Current projects include promotion of Indigenous led action on tobacco control in Aboriginal communities; tobacco industry marketing strategies, product innovation and diversification; illicit trade in tobacco; the environmental impact of tobacco use; as well as comparative analysis of regulatory responses to the tobacco, alcohol and other health harming industries.

A key element of the Programme is the support of student research at SFU and other institutions, and we welcome enquiries from potential students.


We're based in SFU's Faculty of Health Sciences.
Follow us on Twitter or contact us.

 In accordance with World Health Organization recommendations, and policies at institutions where our researchers are employed, the Global Tobacco Control Research Programme at Simon Fraser University will not engage with, or accept funding or support from the tobacco industry, or any allied or affiliated individuals or organisations such as the Phillip Morris-funded "Foundation for a Smoke Free World." This includes the e-cigarette and vaping industries, producers of other ‘new nicotine delivery devices’ and any associated organisations and representatives connected to the tobacco industry.